(SCI) Service International - Overview
Stock: Funeral Services, Cemetery Property, Cremation, Merchandise, Pre-Planning
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.65% |
| Yield on Cost 5y | 2.68% |
| Yield CAGR 5y | 10.25% |
| Payout Consistency | 83.2% |
| Payout Ratio | 48.0% |
| Risk 5d forecast | |
|---|---|
| Volatility | 23.8% |
| Relative Tail Risk | -12.2% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.46 |
| Alpha | 4.95 |
| Character TTM | |
|---|---|
| Beta | 0.267 |
| Beta Downside | 0.193 |
| Drawdowns 3y | |
|---|---|
| Max DD | 25.23% |
| CAGR/Max DD | 0.34 |
Description: SCI Service International January 03, 2026
Service Corporation International (SCI) is the largest provider of death-care products and services in the United States and Canada, operating funeral homes, cemeteries, crematoria, and related ancillary businesses under brands such as Dignity Memorial and Neptune Society. Its offerings span the full funeral value chain-from facility use, embalming, and cremation to merchandise like caskets, urns, and online tributes, as well as interment rights in developed lots, mausoleums, and lawn crypts.
Key recent metrics: FY 2023 revenue reached approximately $5.6 billion, with an adjusted EBITDA margin of roughly 12%, and same-store sales grew about 3% year-over-year. The sector is being driven by two macro trends-an aging U.S. population (the “baby-boomer” cohort is entering the highest mortality age bracket) and a sustained shift toward cremation, which now accounts for about 70% of U.S. dispositions, pressuring traditional burial-related revenue streams.
For a deeper quantitative dive, you may find ValueRay’s SCI valuation model worth reviewing.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 534.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -0.00 > 1.0 |
| NWC/Revenue: -7.75% < 20% (prev -8.53%; Δ 0.79% < -1%) |
| CFO/TA 0.05 > 3% & CFO 994.0m > Net Income 534.6m |
| Net Debt (4.79b) to EBITDA (1.24b): 3.87 < 3 |
| Current Ratio: 0.56 > 1.5 & < 3 |
| Outstanding Shares: last quarter (143.2m) vs 12m ago -2.05% < -2% |
| Gross Margin: 26.44% > 18% (prev 0.26%; Δ 2618 % > 0.5%) |
| Asset Turnover: 23.99% > 50% (prev 23.84%; Δ 0.15% > 0%) |
| Interest Coverage Ratio: 3.81 > 6 (EBITDA TTM 1.24b / Interest Expense TTM 254.5m) |
Altman Z'' 0.36
| A: -0.02 (Total Current Assets 419.7m - Total Current Liabilities 752.2m) / Total Assets 18.36b |
| B: 0.02 (Retained Earnings 440.1m / Total Assets 18.36b) |
| C: 0.05 (EBIT TTM 970.5m / Avg Total Assets 17.88b) |
| D: 0.03 (Book Value of Equity 586.1m / Total Liabilities 16.79b) |
| Altman-Z'' Score: 0.36 = B |
Beneish M -3.28
| DSRI: 0.82 (Receivables 112.5m/133.4m, Revenue 4.29b/4.15b) |
| GMI: 0.98 (GM 26.44% / 25.84%) |
| AQI: 0.86 (AQ_t 0.71 / AQ_t-1 0.83) |
| SGI: 1.03 (Revenue 4.29b / 4.15b) |
| TATA: -0.03 (NI 534.6m - CFO 994.0m) / TA 18.36b) |
| Beneish M-Score: -3.28 (Cap -4..+1) = AA |
What is the price of SCI shares?
Over the past week, the price has changed by +6.99%, over one month by +8.99%, over three months by +5.12% and over the past year by +12.57%.
Is SCI a buy, sell or hold?
- StrongBuy: 4
- Buy: 2
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the SCI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 97.8 | 14.6% |
| Analysts Target Price | 97.8 | 14.6% |
| ValueRay Target Price | 92.8 | 8.7% |
SCI Fundamental Data Overview February 03, 2026
P/E Forward = 18.6916
P/S = 2.6277
P/B = 7.1403
P/EG = 1.5566
Revenue TTM = 4.29b USD
EBIT TTM = 970.5m USD
EBITDA TTM = 1.24b USD
Long Term Debt = 4.96b USD (from longTermDebt, last quarter)
Short Term Debt = 67.3m USD (from shortTermDebt, last quarter)
Debt = 5.03b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.79b USD (from netDebt column, last quarter)
Enterprise Value = 16.06b USD (11.27b + Debt 5.03b - CCE 241.3m)
Interest Coverage Ratio = 3.81 (Ebit TTM 970.5m / Interest Expense TTM 254.5m)
EV/FCF = 25.95x (Enterprise Value 16.06b / FCF TTM 618.9m)
FCF Yield = 3.85% (FCF TTM 618.9m / Enterprise Value 16.06b)
FCF Margin = 14.42% (FCF TTM 618.9m / Revenue TTM 4.29b)
Net Margin = 12.46% (Net Income TTM 534.6m / Revenue TTM 4.29b)
Gross Margin = 26.44% ((Revenue TTM 4.29b - Cost of Revenue TTM 3.16b) / Revenue TTM)
Gross Margin QoQ = 25.10% (prev 25.48%)
Tobins Q-Ratio = 0.87 (Enterprise Value 16.06b / Total Assets 18.36b)
Interest Expense / Debt = 1.31% (Interest Expense 65.7m / Debt 5.03b)
Taxrate = 26.94% (43.3m / 160.9m)
NOPAT = 709.0m (EBIT 970.5m * (1 - 26.94%))
Current Ratio = 0.56 (Total Current Assets 419.7m / Total Current Liabilities 752.2m)
Debt / Equity = 3.21 (Debt 5.03b / totalStockholderEquity, last quarter 1.57b)
Debt / EBITDA = 3.87 (Net Debt 4.79b / EBITDA 1.24b)
Debt / FCF = 7.74 (Net Debt 4.79b / FCF TTM 618.9m)
Total Stockholder Equity = 1.61b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.99% (Net Income 534.6m / Total Assets 18.36b)
RoE = 33.12% (Net Income TTM 534.6m / Total Stockholder Equity 1.61b)
RoCE = 14.76% (EBIT 970.5m / Capital Employed (Equity 1.61b + L.T.Debt 4.96b))
RoIC = 10.82% (NOPAT 709.0m / Invested Capital 6.55b)
WACC = 5.07% (E(11.27b)/V(16.30b) * Re(6.90%) + D(5.03b)/V(16.30b) * Rd(1.31%) * (1-Tc(0.27)))
Discount Rate = 6.90% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -1.88%
[DCF Debug] Terminal Value 87.03% ; FCFF base≈606.3m ; Y1≈652.5m ; Y5≈800.0m
Fair Price DCF = 134.7 (EV 23.67b - Net Debt 4.79b = Equity 18.88b / Shares 140.2m; r=5.90% [WACC]; 5y FCF grow 8.57% → 2.90% )
EPS Correlation: -42.61 | EPS CAGR: -52.50% | SUE: -4.0 | # QB: 0
Revenue Correlation: 32.54 | Revenue CAGR: 0.38% | SUE: 1.38 | # QB: 3
EPS next Quarter (2026-03-31): EPS=1.05 | Chg30d=+0.008 | Revisions Net=-1 | Analysts=6
EPS next Year (2026-12-31): EPS=4.26 | Chg30d=+0.011 | Revisions Net=+0 | Growth EPS=+10.5% | Growth Revenue=+3.5%